Letermovir Prophylaxis in Solid Organ Transplant - CMV Breakthrough and Tacrolimus Drug Interaction

被引：0
|
作者：
Winstead, R. [1 ]
Kumar, D. [1 ]
Brown, A. [1 ]
Yakubu, I. [1 ]
Song, C. [1 ]
Thacker, L. [2 ]
Gupta, G. [1 ]
机构：
[1] Virginia Commonwealth Univ Hlth, Richmond, VA USA
[2] Virginia Commonwealth Univ, Richmond, VA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
821
引用
收藏
页码：844 / 844
页数：1
相关论文
共 50 条
  • [1] Letermovir prophylaxis in solid organ transplant-Assessing CMV breakthrough and tacrolimus drug interaction
    Winstead, Ryan J.
    Kumar, Dhiren
    Brown, Andrew
    Yakubu, Idris
    Song, Chelsey
    Thacker, Leroy
    Gupta, Gaurav
    TRANSPLANT INFECTIOUS DISEASE, 2021,
  • [2] Letermovir For The Treatment And Secondary Prophylaxis Of Drug Resistant CMV In Solid Organ Transplant Recipients.
    Pereira, M. R.
    Aaron, J. G.
    Kubin, C. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 459 - 460
  • [3] Letermovir for CMV Prophylaxis and Treatment of Resistant/Refractory CMV Disease in Solid Organ Transplant Recipients
    Miller, M.
    Scherger, S.
    Benamu, E.
    Bajrovic, V.
    Ramanan, P.
    Madinger, N.
    Barron, M.
    Johnson, S.
    Campbell, T.
    Gray, A.
    Weinberg, A.
    Abidi, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 797 - 797
  • [4] Managing the Significant Drug-Drug Interaction Between Tacrolimus and Letermovir in Solid Organ Transplant Recipients
    Hedvat, J.
    Choe, J.
    Salerno, D.
    Scheffert, J.
    Bley, D.
    Anamisis, A.
    Shertel, T.
    Lee, J.
    Liu, E.
    Lange, N. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 388 - 388
  • [5] Managing the significant drug-drug interaction between tacrolimus and letermovir in solid organ transplant recipients
    Hedvat, Jessica
    Choe, Jason Y.
    Salerno, David M.
    Scheffert, Jenna L.
    Kovac, Danielle
    Anamisis, Anastasia
    Shertel, Tara L.
    Lee, Jennifer H.
    Liu, Esther C.
    Lange, Nicholas W.
    CLINICAL TRANSPLANTATION, 2021, 35 (03)
  • [6] Letermovir for CMV Treatment in Solid Organ Transplant.
    Witkowsky, O.
    Chunduru, M.
    Chung, A.
    Diez, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 721 - 721
  • [7] Use of Letermovir for CMV Prophylaxis or Treatment in Thoracic Organ Transplant Recipients
    King, C. S.
    Aryal, S. S.
    Cochrane, A.
    Brown, A.
    Shlobin, O.
    Ahmad, K.
    Marinak, L.
    Fregoso, M.
    Chun, J.
    Nathan, S.
    Shah, P.
    Desai, S.
    Katugaha, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S119 - S120
  • [8] Breakthrough CMV Viremia Outcomes of Letermovir Prophylaxis in Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide
    Nguyen, Arthur
    Bubalo, Joseph S.
    Saultz, Jennifer N.
    Hayes-Lattin, Brandon
    Chen, Andy
    Cook, Rachel J.
    Gandhi, Arpita
    Leonard, Jessica
    Maziarz, Richard T.
    Migdady, Yazan
    Nemecek, Eneida R.
    Schachter, Levanto
    BLOOD, 2022, 140 : 12856 - 12858
  • [9] Breakthrough CMV Infections on Letermovir Prophylaxis in CMV-Seropositive Allogeneic Hematopoeitic Cell Transplant (allo-HCT) Recipients
    Shigle, Terri Lynn
    Handy, Victoria Wehr
    Foolad, Farnaz
    Khawaja, Fareed
    Aitken, Samuel L.
    Chemaly, Roy F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [10] Letermovir is Effective for Cytomegalovirus Prophylaxis in a Large, Heterogeneous Solid Organ Transplant Population
    Codispodo, G. N.
    Burack, D.
    Salerno, D. M.
    Lange, N. W.
    Hedvat, J.
    Kovac, D.
    Pereira, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S587 - S587
12345